Overview

Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section

Status:
Unknown status
Trial end date:
2015-09-01
Target enrollment:
0
Participant gender:
Female
Summary
In this study, the efficacy and safety of tranexamic acid in the reducing the blood loss during and after elective LSCS will be investigated.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ain Shams Maternity Hospital
Treatments:
Tranexamic Acid
Criteria
Inclusion Criteria:

- - Women undergoing caesarean delivery for various elective indications.

- Full term primiparas / multiparas.

- Singleton pregnancy being delivered by LSCS.

Exclusion Criteria:

- - Medical problems involving the heart, liver, kidney and brain .

- Blood disorders.

- Allergy to tranexamic acid.

- History of thromboembolic disorders, abnormal placentation, severe pre-eclampsia,
uterine anomalies and pathology.

- Multiple pregnancy, macrosomia.

- Polyhydromnios .

- Patients requiring blood transfusion due to anemia